Imperial College London

Dr Hannah M Cheeseman

Faculty of MedicineDepartment of Infectious Disease

Postdoctoral Researcher & Clinical Trials Laboratory Manager



+44 (0)20 7594 2540hannah.cheeseman




452 - Shattock GroupNorfolk PlaceSt Mary's Campus






Day S, Kaur C, Cheeseman H, et al., 2022, Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens, Frontiers in Immunology, Vol:13, ISSN:1664-3224, Pages:1-17

Elliott T, Cheeseman HM, Evans AB, et al., 2022, Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines, Plos Pathogens, Vol:18, ISSN:1553-7366, Pages:1-20

Pollock KM, Cheeseman HM, Szubert AJ, et al., 2022, Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial, Eclinicalmedicine, Vol:44, ISSN:2589-5370

Cole ME, Guo Y, Cheeseman HM, et al., 2022, Multicolor Flow Cytometry and High-Dimensional Data Analysis to Probe Complex Questions in Vaccinology., Methods Mol Biol, Vol:2414, Pages:433-447

Moshe M, Daunt A, Flower B, et al., 2021, SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (REACT2): diagnostic accuracy study, Bmj: British Medical Journal, Vol:372, ISSN:0959-535X, Pages:1-8

More Publications